Vident Advisory’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$201K Sell
2,230
-275
-11% -$23.3K ﹤0.01% 1795
2026
Q1
$209K Buy
+2,505
New +$206K ﹤0.01% 1682
2025
Q4
– Sell
-2,227
Closed -$211K – 1680
2025
Q3
$211K Buy
+2,227
New +$210K ﹤0.01% 1547
2024
Q2
– Sell
-2,761
Closed -$225K – 1458
2024
Q1
$225K Buy
+2,761
New +$216K ﹤0.01% 1163

Other funds holding HQY

Vident Advisory's HQY Position: Q2 2026 in Review

Vident Advisory reduced its HealthEquity (HQY) stake by 11% in Q2 2026, selling an estimated $23.3K and leaving 2,230 shares worth $201K. The position accounts for ﹤0.01% of the portfolio, ranked #1795.

Vident Advisory first reported a position in HQY in Q1 2024 and has held it in 4 quarters since. The position peaked at $225K in Q1 2024. 501 funds tracked by Wall St. Rank hold HQY as of Q2 2026.

  • Vident Advisory held 2,230 shares of HealthEquity worth $201K as of Q2 2026.
  • Vident Advisory sold 275 HealthEquity shares in Q2 2026, an estimated $23.3K.
  • HealthEquity made up ﹤0.01% of Vident Advisory's portfolio in Q2 2026, its #1795 holding.
  • Vident Advisory first reported a position in HealthEquity in Q1 2024 and has held it in 4 quarters since.
  • Vident Advisory's HealthEquity position peaked at $225K in Q1 2024.
  • 501 funds tracked by Wall St. Rank held HealthEquity as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.